Marsha Alpert Chandler, a director of Biocept, recently acquired 4,545 shares of the company. The buys took place at prices ranging from $0.00 to $1.10 per share, on dates ranging from March 04 to October 19, 2016. Chandler now owns 6,905 shares of the company. At least some of the disposals which took place during this transaction were gifts or donations. Chandler operates out of San Diego, CA. Some additional info was provided as follows:
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,333 fewer shares with respect to these shares.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 3,385 fewer shares with respect to thes
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept Just Filed Its Quarterly Report:
10. Net Loss per Co... - May 15, 2017
Securities to be offered to employees in employee benefit plans - May 15, 2017
Biocept Reports First Quarter 2017 Financial Results - May 11, 2017
Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017